Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Does Overall Survival Benefit From Complete Pathologic Responders Vary With Treatment Approach?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fields RC, Strong VE, Gönen M, et al. Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer. 2011;104:1840–7.

    Article  CAS  Google Scholar 

  2. Badgwell B, Blum M, Estrella J, et al. Predictors of survival in patients with resectable gastric cancer treated with preoperative chemoradiation therapy and gastrectomy. J Am Coll Surg. 2015;221:83–90.

    Article  Google Scholar 

  3. Trumbull DA, Lemini R, Díaz Vico T, et al. Prognostic significance of complete pathologic response obtained with chemotherapy versus chemoradiotherapy in gastric cancer. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08921-9.

    Article  PubMed  Google Scholar 

  4. Cats A, Jansen EPM, van Grieken N, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018;19:616–28.

    Article  CAS  Google Scholar 

  5. Leong T, Smithers BM, Haustermans K, et al. TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results from an international, intergroup trial of the AGITG, TROG, EORTC, and CCTG. Ann Surg Oncol. 2017;24:2252–8.

    Article  Google Scholar 

Download references

Acknowledgments

This study was supported by the Roswell Park Cancer Institute and National Cancer Institute (NCI) (Grant No. P30CA016056).

Author information

Authors and Affiliations

  1. College of Medicine, University of Florida, Gainesville, FL, USA

    Denslow A. Trumbull BS

  2. Department of Surgery, Mayo Clinic, Jacksonville, FL, USA

    Emmanuel Gabriel MD, PhD

  3. Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

    Moshim Kukar MD

Authors
  1. Denslow A. Trumbull BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanuel Gabriel MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Moshim Kukar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Moshim Kukar MD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trumbull, D.A., Gabriel, E. & Kukar, M. ASO Author Reflections: Does Overall Survival Benefit From Complete Pathologic Responders Vary With Treatment Approach?. Ann Surg Oncol 27 (Suppl 3), 888–889 (2020). https://doi.org/10.1245/s10434-020-09012-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09012-5

Search

Navigation